Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/2003
07/15/2003US6592860 Composition and applicator for topical substance delivery
07/15/2003CA2262269C Treatment of skeletal disorders
07/15/2003CA2238465C Triaromatic compounds, compositions containing them and uses
07/10/2003WO2003055916A2 Adiponectin fragments and conjugates
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/10/2003WO2003055875A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
07/10/2003WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
07/10/2003WO2003055865A1 Quinazolinone derivative
07/10/2003WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
07/10/2003WO2003055500A1 Pharmaceutical compositions for the treatment or prevention of osteoporosis
07/10/2003WO2003055496A1 Method for the treatment of bone disorders
07/10/2003WO2003055495A1 ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17β-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
07/10/2003WO2003055484A1 Urea derivatives
07/10/2003WO2003055481A1 Organ fibrosis inhibitors
07/10/2003WO2003055477A1 Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003033677A3 Dimerized growth factor and materials and methods for producing it
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002038764A3 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030130517 Useful as antiinflammatory drugs, particularly as remedies for rheumatoid arthritis
07/10/2003US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction
07/10/2003US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents
07/10/2003US20030130337 Indole derivatives as anti-inflammatory agents
07/10/2003US20030130333 Combination product and methods of use
07/10/2003US20030130328 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
07/10/2003US20030130325 Substituted tryptophan derivatives
07/10/2003US20030130319 Aminopyrrole compounds
07/10/2003US20030130309 Antiinflammatory agents; rheumatic diseases
07/10/2003US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents
07/10/2003US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents
07/10/2003US20030130285 Controlling cell differentiation, cell proliferation
07/10/2003US20030130283 CRF receptor antagonists and methods relating thereto
07/10/2003US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/10/2003US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators
07/10/2003US20030130274 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130256 Stimulant of central nervous system regeneration
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130201 Mixture with ascorbic acid, proline and lysine
07/10/2003US20030130200 Tripeptide or tetrapeptide
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130168 Reverse-turn mimetics and methods relating thereto
07/10/2003US20030130165 Method for treating neurodegenerative disorders
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129703 Modified dorsal tissue affecting factor and compositions
07/10/2003US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
07/10/2003US20030129294 Hydroquinone-substituted fatty acid for use in foods; lipase inhibitors; peroxisome proliferator activated receptors; antiaging agents
07/10/2003US20030129235 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
07/10/2003US20030129188 Peptide mimetics; catalytic antibodies such as aldolase, beta-lactamase, esterase, or amidase; for treatment of angiogenesis, bone metabolism disorders, inflammation, or cell growth disorders
07/10/2003US20030129181 Hydrolases modified by polyoxyethylene glycol for induction of high plasmatic levels of free tumor necrosis factor
07/10/2003US20030129129 Prevention, therapy disease; forming tritiated water; calibration
07/10/2003CA2471348A1 Quinazolinone derivative
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471236A1 Urea derivatives
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003CA2468619A1 Adiponectin fragments and conjugates
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325930A1 Mammal prolactin variants
07/09/2003EP1325914A1 Tetrahydroquinoline compounds
07/09/2003EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
07/09/2003EP1325749A1 Bone metabolism improving agent
07/09/2003EP1325682A1 Food or pet food composition containing plant extracts for maintenance of bone health and prevention or treatment of bone diseases
07/09/2003EP1325681A1 Composition for promotion of bone growth and maintenance of bone health
07/09/2003EP1325341A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins
07/09/2003EP1325137A2 Truncated phosphodiesterase-7 polypeptides
07/09/2003EP1325122A2 Modulation of the transcription of pro-inflammatory gene products
07/09/2003EP1325117A2 Lipid metabolism enzymes
07/09/2003EP1325028A2 New inhibitors of iapp fibril formation and uses thereof
07/09/2003EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
07/09/2003EP1324994A2 Tricyclic compounds and uses thereof
07/09/2003EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
07/09/2003EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions
07/09/2003EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition
07/09/2003EP1324759A2 Nf-g(k)b inhibitors
07/09/2003EP1324750A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
07/09/2003EP1272232A4 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
07/09/2003EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
07/09/2003EP0888353B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE
07/09/2003CN1429222A 激酶抑制剂 Kinase inhibitors
07/09/2003CN1429202A Compounds for modulating cell proliferation
07/09/2003CN1429200A Anthranyl amides and their use as medicaments
07/09/2003CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof
07/09/2003CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
07/09/2003CN1429108A 磷酸盐运输抑制剂 Phosphate transport inhibitor
07/09/2003CN1428426A Programmed cell death induction molecule II
07/09/2003CN1428167A Lingxian Jingjiantong granules Chinese medicine preparation and its preparation method
07/09/2003CN1428155A Medicine for curing cervical spondylopathy
1 ... 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 ... 820